维普中文期刊产品整合服务
17篇 您的检索式:作者名="SJ Houston"
    题名 作者 年代 出处 被引量
1Comparison of fresh and cryopreserved rat hepatocyte suspensions for the prediction of in vitro intrinsic clearance显示文摘GRIFFIN SJ HOUSTON JB 2004Drug Metab Dispos2004,32,5:1
2Prediction of in vitro intrinsic clearance from hepatocytes:comparison of suspensions and monolayer cultures显示文摘GRIFFIN SJ HOUSTON JB 2005Drug Metab Dispos2005,33,1:1
3Overexpression of c-erbB2 is an independent marker of resistance to endocrine therapy in advanced breast cancer显示文摘Houston SJ Plunkett TA Barnes DM 1999Br J Cancer1999,79,8:1
4Palliation of pain associated with metastatic bone cancer using samarium-153 lexidronam:a doudle-blind placebo-controlled clinical trial显示文摘Seraflni AN Houston SJ Resche I 0,,04:1
5Overexpression of c-erbB2 is an independent marker of resistance to endocrine therapy in advanced breast cancer显示文摘Houston SJ Plunkett TA Barnes DM 1999Br J Cancer1999,79,78:1
6Overexpression of c-erbB2 is an independent marker of resistance to endocrine therapy in advanced breast cancer显示文摘Houston SJ Plunkett TA Barnes DM 1999Br J Cancer1999,78,78:1
7The systemic treatment of bone metastases显示文摘Houston SJ Rubens RD 1995Clin Orthop1995,31,2:1
8Palliation of pain associated with metastatic bone cancer using samarium-153 lexidronam: A double-blind placebo-controlled clinical trial显示文摘Serafini AN Houston SJ Resche I Quick DP Grund FM Ell PJ Bertrand A Ahmann FR Orihuela E Reid RH Lerski RA Collier BD McKillop JH Purnell GL Pecking AP Thomas FD Harrison KA 1998Journal of Clinical Oncology1998,16,4:1
9Overexpression of c-erbB2 is an independent marker of resistance to endocrine therapy in advanced breast cancer显示文摘Houston SJ Plunkett TA Barnes DM 0,,7:1
10Overexpression of c-erbB2 is an independent marker of resistance to endocrine therapy in advanced breast cancer显示文摘Houston SJ Plunkett TA Barnes DM 1999Br J Cancer1999,79,78:1
11Palliation of pain associated with metastatic bone cancer using samarium-153 lexidronam:a double-blind placebo-controlled clinical trial显示文摘Serafini AN Houston SJ Resche I 1998J Clin Oncol1998,16,:1
12Palliation of painassociated w ith metastatic bone cancer using samarium-153lexidronam: a double-blind placebo-controlled study显示文摘Serafini AN Houston SJ Resche I 1998J ClinOncol1998,16,4:1
13COX-2 Inhibitors:a review显示文摘Houston AM Teach SJ 2004Pediatr Emerg Care2004,20,:1
14Overexpression of c-cerbB2 is an independent marker of resistance to endocrine therapy in advanced breast cancer显示文摘SJ Houston TA Plunkett DM Barnes 1999British Journal of Cancer1999,79,:1
15The systemic treatment of bone metastases显示文摘Houston SJ Rubens RD 1995Clin Orthop1995,312,:1
16The systemic treatment of bone metasta- ses 显示文摘Houston SJ Rubens RD 1995Clin Orthop Relat Res1995,,312:1
17Patterns in lung cancer inci- dence rates and trends by hlstologic type in the United States, 2004 -2009显示文摘Houston KA Henley SJ Li J 2014Lung cancer2014,86,1:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费